Correlation between tumor angiogenesis and expression of thymidine phosphorylase, and patient outcome in uterine cervical carcinoma

Human Pathology

Volumn 30, Issue 11, 1999, Pages 1389-1394

  Ueda, Masatsugu ^a   Terai, Yoshito ^a   Kumagai, Koji ^a   Ueki, Ken ^a   Okamoto, Yoshiaki ^a   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Angiogenesis; Prognosis; Thymidine phosphorylase; Uterine cervical carcinoma

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SURVIVAL; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MYOMETRIUM; PROGNOSIS; UTERINE CERVIX CARCINOMA;

EID: 0032695353     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90074-6     Document Type: Article

References (36)

1. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763, 1995
2. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
3. Toi M, Hoshina S, Taniguchi T, et al: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 64:79-82, 1995
4. Weidner N, Carrol PR, Flax J, et al: Tumor angiogenesis correlated with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
5. Tanigawa, N, Amaya H, Matsumura M, et al: Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma. Cancer Lett 108:281-290, 1996
6. Tanigawa N, Amaya H, Matsumura M, et al: Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15:826-832, 1997
7. Tanigawa N, Amaya H, Matsumura M, et al: Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 57:1043-1046, 1997
8. Kainz C, Speiser P, Wanner C, et al: Prognostic value of tumor microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res 15:1549-1551, 1995
9. Rutgers JL, Mattox TF, Vargas P: Angiogenesis in uterine cervical squamous cell carcinoma. Int J Gynecol Pathol 14:114-118, 1995
10. Wiggins DL, Granai CO, Steinhoff MM, et al: Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 56:353-356, 1995
11. Guidi AJ, Abu-Jawdeh G, Berse B, et al: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87:1237-1245, 1995
12. Dinh TV, Hannigan EV, Smith ER, et al: Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol 87:751-754, 1996
13. Bremer GL, Tiebosch A, Putten H, et al: Tumor angiogenesis: An independent prognostic parameter in cervical cancer. Am J Obstet Gynecol 174:126-131, 1996
14. Kirschner CV, Alanis-Amezua JM, Martin VG, et al: Angiogenesis factor in endometrial carcinoma: A new prognostic indicator? Am J Obstet Gynecol 174:1879-1884, 1996
15. Kaku T, Kamura T, Kinukawa N, et al: Angiogenesis in endometrial carcinoma. Cancer 80:741-747, 1997
16. Fujiwaki R, Hata K, Iida K, et al: Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol 68:247-252, 1998
17. Hollingsworth HC, Kohn EC, Steinberg SM, et al: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147:33-41, 1995
18. Schoell WMJ, Pieber D, Reich O, et al: Tumor angiogenesis as a prognostic factor in ovarian carcinoma. Cancer 80:2257-2262, 1997
19. Nakanishi Y, Kodama J, Tokumo K, et al: The expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase associates with angiogenesis in epithelial ovarian cancer. Int J Clin Oncol 2:219-223, 1997
20. Connolly DT: Vascular permeability factor: A unique regulator of blood vessel function. J Cell Biochem 47:219-223, 1991
21. Ohtani H, Nakamura S, Watanabe Y, et al: Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 68:520-527, 1993
22. Malden LT, Novak U, Burgess AW: Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract. Int J Cancer 43:380-384, 1989
23. Folkman J, Klagsburn M: Angiogenic factors. Science 235:442-447, 1987
24. Furukawa T, Yoshimura A, Sumizawa T, et al: Angiogenic factor. Nature (Lond) 356:668, 1992
25. Moghaddam A, Zhang HT, Fan TPD, et al: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 92:998-1002, 1995
26. Haraguchi M, Miyadera K, Uemura K, et al: Angiogenic activity of enzymes. Nature (Lond), 368:198, 1994
27. Ueda M, Ueki K, Kumagai K, et al: Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy. Cancer Res 58:2343-2346, 1998
28. International Federation of Gynecology and Obstetrics Cancer Committee: Staging announcement. Gynecol Oncol 25:383-385, 1986
29. Imai T: Growth patterns in human carcinoma. Obstet Gynecol 16:296-308, 1960
30. Fox SB, Westwood M, Moghaddam A, et al: The antigenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73:275-280, 1996
31. O'Brien TS, Fox SB, Dickison AJ, et al: Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56:4799-4804, 1994
32. Maeda K, Chung YS, Ogawa S, et al: Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73:884-888, 1996
33. Takebayashi Y, Miyadera K, Akiyama S, et al: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87:288-295, 1996
34. Takebayashi Y, Akiyama S, Akiba S, et al: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88:1110-1117, 1996
35. Haraguchi M, Furukawa T, Sumizawa T, et al: Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 53:5680-5683, 1993
36. Ueda M, Ueki M, Terai Y, et al: Stimulatory effects of EGF and TGF-α on invasive activity and 5′-deoxy-5-fluorouridine sensitivity in uterine cervical carcinoma SKG-IIIb cells. Int J Cancer 72:1027-1033, 1997